The diagnosis of AQP4‐/MOG‐IgG double seronegative NMOSD is currently made according to criteria proposed by the International Panel for NMO Diagnosis (IPND), which are based on clinical and radiological similarities with the classic phenotype associated with AQP4‐IgG seropositive NMSOD. This evidence concerns the gene MOG and neuromyelitis optica.